Skip to main content
Fig. 3 | European Radiology Experimental

Fig. 3

From: Contrast-enhanced mammography (CEM) versus MRI for breast cancer staging: detection of additional malignant lesions not seen on conventional imaging

Fig. 3

Case number 1 of Table 3. A 64-year-old woman presented with a calcified right breast mass at 12 o’clock on screening mammography, a grade 3 infiltrating ductal carcinoma. CC (a) and MLO (b) recombined CEM images show an enhancing spiculated mass (dotted arrows). Enhancing satellite foci are also visible on the MLO projection. MRI axial (c, f) and sagittal (d, e) contrast-enhanced T1-weighted subtracted images show the dominant lesion (dotted arrows) and an additional enhancing lesion solid (solid arrows) 2 cm infero-laterally. No corresponding finding was detected laterally on CEM. Mastectomy revealed a multifocal grade 3 invasive ductal carcinoma, oestrogen-, progesterone- and Her2 receptor-positive, with associated high-grade ductal carcinoma in situ. The additional lesion was a grade 2 invasive ductal carcinoma. CC Craniocaudal, CEM Contrast-enhanced mammography, MLO Mediolateral, MRI Magnetic resonance imaging

Back to article page